Cytodyn Inc (CYDY)

[ScienceOC]

If we know the mechanism of action, which looks like cytokine storm, then Leronlimab will treat any diseases and infections (viral or bacterial) that can trigger the cytokine storm.

If Leronlimab can calm the storm and cause homeostasis of the patient's immune system to combat the virus, then this will be a game changer for sure.

I think there are other CCL5 receptor antibodies, like Leronlimab, but Leronlimab has shown outstanding safety record in clinical trials with HIV. This gives Leronlimab the edge over other CCL5 receptor antibodies.

I cannot wait till the data from double blinded studies is revealed.
This will be the answer to many of the questions we currently are asking.

Once this data comes out and papers are published in the journal, then there is nothing that can stop Leronlimab!

If data is positive, then Leronlimab will save many lives!